{
 "PrintNo":"S5158","Session":2021,"Chamber":"SENATE","BillType":"Senate","Published":"2021-02-25T14:02:41.370573Z",
 "Status":"IN_SENATE_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2022-01-05","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2021-02-25","Chamber":"SENATE"},
  {"Text":"REFERRED TO HEALTH","Date":"2022-01-05","Chamber":"SENATE"}
 ],
 "Sponsors":[{"ID":409,"Name":"Andrew J. Lanza","Short":"LANZA"}],
 "Title":"Requires the commissioner of health to establish and publish a list of generic drug products; repealer",
 "Summary":"Requires the commissioner of health to establish and publish a list of generic drug products.",
 "LawSection":"Public Health Law",
 "LawCode":"Rpld §206 sub 1 ¶(o), add §280-d, Pub Health L; amd §§6810 & 6816-a, Ed L",
 "ActClause":"AN ACT to amend the public health law and the education law, in relation to generic drug products; and to repeal paragraph (o) of subdivision 1 of section 206 of the public health law relating thereto",
 "SameAsPrintNo":"A1923-2021","PreviousVersions":["S6739-2013","S5099-2015","S5471-2017","S2391-2019"]
}